Patents by Inventor Rune Viig Overgaard

Rune Viig Overgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-KIR antibodies, formulations, and uses thereof
    Patent number: 10815299
    Abstract: A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: October 27, 2020
    Assignee: NOVO NORDISK A/S
    Inventors: Peter Andreas Nicolai Reumert Wagtmann, Ivan Svendsen, Rozana Sten, Lene Hjorth Alifrangis, Rune Viig Overgaard
  • ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
    Publication number: 20180208652
    Abstract: A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer.
    Type: Application
    Filed: December 20, 2017
    Publication date: July 26, 2018
    Inventors: Peter Andreas Nicolai Reumert WAGTMANN, Ivan SVENDSEN, Rozana STEN, Lene Hjorth ALIFRANGIS, Rune Viig OVERGAARD
  • Anti-KIR antibodies, formulations, and uses thereof
    Patent number: 9879082
    Abstract: A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: January 30, 2018
    Assignee: NOVO NORDISK A/S
    Inventors: Peter Andreas Nicolai Reumert Wagtmann, Ivan Svendsen, Rozana Sten, Lene Hjorth Alifrangis, Rune Viig Overgaard
  • ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
    Publication number: 20150197569
    Abstract: A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer.
    Type: Application
    Filed: January 27, 2015
    Publication date: July 16, 2015
    Inventors: Peter Andreas Nicolai Reumert Wagtmann, Ivan Svendsen, Rozana Sten, Lene Hjorth Alifrangis, Rune Viig Overgaard
  • ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
    Publication number: 20100189723
    Abstract: A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer.
    Type: Application
    Filed: January 11, 2008
    Publication date: July 29, 2010
    Inventors: Peter Andreas Nicolai Reumert Wagtmann, Ivan Svendsen, Rozana Sten, Lene-Hjorth Alifrangis, Rune Viig Overgaard